Electrophysiologic effects of amiodarone: Experimental and clinical observation relative to serum and tissue drug concentrations
- 1 October 1984
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 108 (4) , 890-898
- https://doi.org/10.1016/0002-8703(84)90451-4
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.Circulation, 1982
- Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: Potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardiaAmerican Heart Journal, 1982
- AmiodaroneNew England Journal of Medicine, 1981
- Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.Circulation, 1981
- Control of refractory life-threatening ventricular tachyarrhythmias by amiodaroneAmerican Heart Journal, 1981
- Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmiasAmerican Heart Journal, 1981
- Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.Heart, 1980
- Effect of Amiodarone in the Wolff‐Parkinson‐White SyndromeActa Medica Scandinavica, 1979
- Clinical efficacy of amiodarone as an antiarrhythmic agentThe American Journal of Cardiology, 1976
- Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochlorideThe American Journal of Cardiology, 1974